Dmitry Balyasny’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.17M Buy
3,000
+800
+36% +$319K ﹤0.01% 2149
2026
Q2
$851K Buy
+2,200
New +$816K ﹤0.01% 2299
2026
Q1
– Sell
-13,500
Closed -$4.73M – 3055
2025
Q4
$4.73M Sell
13,500
-2,000
-13% -$676K 0.01% 1423
2025
Q3
$5.01M Sell
15,500
-17,000
-52% -$5.29M 0.01% 1371
2025
Q2
$12.6M Hold
32,500
– – 0.02% 860
2025
Q1
$14.1M Hold
32,500
– – 0.02% 745
2024
Q4
$12M Sell
32,500
-2,200
-6% -$921K 0.02% 882
2024
Q3
$18M Sell
34,700
-1,900
-5% -$1.02M 0.03% 678
2024
Q2
$19.8M Sell
36,600
-1,500
-4% -$793K 0.03% 608
2024
Q1
$19.8M Buy
38,100
+32,600
+593% +$16.2M 0.03% 622
2023
Q4
$2.59M Buy
5,500
+1,400
+34% +$647K ﹤0.01% 1370
2023
Q3
$1.79M Buy
+4,100
New +$1.86M ﹤0.01% 1407
2022
Q3
– Sell
-2,500
Closed -$1.21M – 2938
2022
Q2
$1.21M Buy
+2,500
New +$1.24M ﹤0.01% 1678
2021
Q3
– Sell
-2,200
Closed -$840K – 2069
2021
Q2
$840K Buy
+2,200
New +$841K ﹤0.01% 1368
2019
Q3
– Sell
-20,000
Closed -$5.88M – 1278
2019
Q2
$5.88M Buy
+20,000
New +$5.46M 0.04% 549
2017
Q2
– Sell
-85,000
Closed -$14.1M – 1536
2017
Q1
$14.1M Buy
+85,000
New +$13.5M 0.07% 379

Other funds holding ELV

Dmitry Balyasny's ELV Position: Q3 2026 in Review

Dmitry Balyasny reduced its Elevance Health (ELV) stake by 10% in Q3 2026, selling an estimated $400K and leaving 8,924 shares worth $3.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1614.

Dmitry Balyasny first reported a position in ELV in Q4 2015 and has held it in 33 quarters since. The position peaked at $89.6M in Q2 2024. 1,627 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Dmitry Balyasny held 8,924 shares of Elevance Health worth $3.47M as of Q3 2026.
  • Dmitry Balyasny sold 1,003 Elevance Health shares in Q3 2026, an estimated $400K.
  • Elevance Health made up ﹤0.01% of Dmitry Balyasny's portfolio in Q3 2026, its #1614 holding.
  • Dmitry Balyasny first reported a position in Elevance Health in Q4 2015 and has held it in 33 quarters since.
  • Dmitry Balyasny's Elevance Health position peaked at $89.6M in Q2 2024.
  • 1,627 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.